71.64
+1.67
+(2.39%)
At close: April 17 at 4:00:00 PM EDT
71.15
-0.49
(-0.68%)
After hours: April 17 at 7:33:47 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
1,141,752
732,384
482,459
293,824
Total Liabilities Net Minority Interest
71,960
31,823
19,481
8,787
Total Equity Gross Minority Interest
1,069,792
700,561
462,978
285,037
Total Capitalization
1,069,792
700,561
462,978
285,037
Common Stock Equity
1,069,792
700,561
462,978
285,037
Net Tangible Assets
1,069,792
700,561
462,978
285,037
Working Capital
1,078,428
694,665
458,510
281,841
Invested Capital
1,069,792
700,561
462,978
285,037
Tangible Book Value
1,069,792
700,561
462,978
285,037
Share Issued
71,344.82
64,065.15
56,668.96
48,297.43
Ordinary Shares Number
71,344.82
64,065.15
56,668.96
48,297.43
12/31/2021 - 7/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACLX Arcellx, Inc.
62.02
+2.19%
RVMD Revolution Medicines, Inc.
36.76
+1.55%
XENE Xenon Pharmaceuticals Inc.
35.11
+3.94%
PTCT PTC Therapeutics, Inc.
47.39
+2.11%
PCVX Vaxcyte, Inc.
30.65
+5.25%
MRUS Merus N.V.
43.06
+2.73%
CRNX Crinetics Pharmaceuticals, Inc.
30.42
+2.84%
APGE Apogee Therapeutics, Inc.
33.11
+3.34%
SRRK Scholar Rock Holding Corporation
30.75
+3.33%
PTGX Protagonist Therapeutics, Inc.
46.28
+1.05%